Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) Stock Competitors & Peer Comparison
See (BBNX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BBNX | $9.37 | +1.85% | 421.6M | -6.91 | -$1.37 | N/A |
| SIRO | $109.97 | +0.00% | 22B | N/A | N/A | N/A |
| HIMS | $22.82 | -5.85% | 5.5B | -278.44 | -$0.09 | N/A |
| NVST | $23.54 | -1.34% | 3.8B | 58.08 | $0.40 | N/A |
| NAKA | $0.18 | -0.87% | 3.7B | -0.40 | -$0.47 | N/A |
| CON | $26.15 | -0.19% | 3.3B | 18.62 | $1.39 | +0.97% |
| CV | $6.67 | -8.63% | 321.7M | -6.27 | -$1.03 | N/A |
| KDLY | $11.30 | +1.16% | 68.1M | -15.48 | -$0.73 | N/A |
| NEUE | $6.75 | +0.00% | 60.9M | -0.38 | -$17.65 | N/A |
| PARK | $18.31 | +1.84% | 35.2M | -100.61 | -$0.18 | N/A |
Stock Comparison
BBNX vs SIRO Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, BBNX is priced at $9.37, while SIRO trades at $109.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas SIRO's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, BBNX is more volatile compared to SIRO. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check SIRO's competition here
BBNX vs HIMS Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, HIMS has a market cap of 5.5B. Regarding current trading prices, BBNX is priced at $9.37, while HIMS trades at $22.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas HIMS's P/E ratio is -278.44. In terms of profitability, BBNX's ROE is -0.23%, compared to HIMS's ROE of -0.02%. Regarding short-term risk, BBNX is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check HIMS's competition here
BBNX vs NVST Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, NVST has a market cap of 3.8B. Regarding current trading prices, BBNX is priced at $9.37, while NVST trades at $23.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas NVST's P/E ratio is 58.08. In terms of profitability, BBNX's ROE is -0.23%, compared to NVST's ROE of +0.02%. Regarding short-term risk, BBNX is more volatile compared to NVST. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check NVST's competition here
BBNX vs NAKA Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, NAKA has a market cap of 3.7B. Regarding current trading prices, BBNX is priced at $9.37, while NAKA trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas NAKA's P/E ratio is -0.40. In terms of profitability, BBNX's ROE is -0.23%, compared to NAKA's ROE of -0.85%. Regarding short-term risk, BBNX is less volatile compared to NAKA. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check NAKA's competition here
BBNX vs CON Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, CON has a market cap of 3.3B. Regarding current trading prices, BBNX is priced at $9.37, while CON trades at $26.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas CON's P/E ratio is 18.62. In terms of profitability, BBNX's ROE is -0.23%, compared to CON's ROE of +0.46%. Regarding short-term risk, BBNX is more volatile compared to CON. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check CON's competition here
BBNX vs CV Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, CV has a market cap of 321.7M. Regarding current trading prices, BBNX is priced at $9.37, while CV trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas CV's P/E ratio is -6.27. In terms of profitability, BBNX's ROE is -0.23%, compared to CV's ROE of +1.27%. Regarding short-term risk, BBNX is less volatile compared to CV. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check CV's competition here
BBNX vs KDLY Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, KDLY has a market cap of 68.1M. Regarding current trading prices, BBNX is priced at $9.37, while KDLY trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas KDLY's P/E ratio is -15.48. In terms of profitability, BBNX's ROE is -0.23%, compared to KDLY's ROE of -0.85%. Regarding short-term risk, BBNX is more volatile compared to KDLY. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check KDLY's competition here
BBNX vs NEUE Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, NEUE has a market cap of 60.9M. Regarding current trading prices, BBNX is priced at $9.37, while NEUE trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas NEUE's P/E ratio is -0.38. In terms of profitability, BBNX's ROE is -0.23%, compared to NEUE's ROE of +0.09%. Regarding short-term risk, BBNX is more volatile compared to NEUE. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check NEUE's competition here
BBNX vs PARK Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, PARK has a market cap of 35.2M. Regarding current trading prices, BBNX is priced at $9.37, while PARK trades at $18.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas PARK's P/E ratio is -100.61. In terms of profitability, BBNX's ROE is -0.23%, compared to PARK's ROE of -0.06%. Regarding short-term risk, BBNX is more volatile compared to PARK. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check PARK's competition here
BBNX vs BRK Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, BRK has a market cap of 11.6M. Regarding current trading prices, BBNX is priced at $9.37, while BRK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas BRK's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to BRK's ROE of N/A. Regarding short-term risk, BBNX is more volatile compared to BRK. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check BRK's competition here
BBNX vs PFSA Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, PFSA has a market cap of 247.9K. Regarding current trading prices, BBNX is priced at $9.37, while PFSA trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas PFSA's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to PFSA's ROE of +0.82%. Regarding short-term risk, BBNX is less volatile compared to PFSA. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check PFSA's competition here
BBNX vs SPNC Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, SPNC has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while SPNC trades at $38.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas SPNC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to SPNC's ROE of -0.61%. Regarding short-term risk, BBNX is more volatile compared to SPNC. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check SPNC's competition here
BBNX vs MZOR Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, MZOR has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while MZOR trades at $58.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas MZOR's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to MZOR's ROE of -0.14%. Regarding short-term risk, BBNX is more volatile compared to MZOR. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check MZOR's competition here
BBNX vs PMC Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, PMC has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while PMC trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas PMC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to PMC's ROE of +0.04%. Regarding short-term risk, BBNX is more volatile compared to PMC. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check PMC's competition here
BBNX vs SCAI Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, SCAI has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while SCAI trades at $55.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas SCAI's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to SCAI's ROE of +0.09%. Regarding short-term risk, BBNX is more volatile compared to SCAI. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check SCAI's competition here
BBNX vs STJ Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, STJ has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while STJ trades at $80.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas STJ's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to STJ's ROE of +0.21%. Regarding short-term risk, BBNX is more volatile compared to STJ. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check STJ's competition here
BBNX vs DSCI Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, DSCI has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while DSCI trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas DSCI's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to DSCI's ROE of -0.00%. Regarding short-term risk, BBNX is more volatile compared to DSCI. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check DSCI's competition here
BBNX vs AMSG Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, AMSG has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while AMSG trades at $67.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas AMSG's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to AMSG's ROE of +0.08%. Regarding short-term risk, BBNX is more volatile compared to AMSG. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check AMSG's competition here
BBNX vs SPAN Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, SPAN has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while SPAN trades at $29.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas SPAN's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to SPAN's ROE of +0.17%. Regarding short-term risk, BBNX is less volatile compared to SPAN. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check SPAN's competition here
BBNX vs EXAC Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, EXAC has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while EXAC trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas EXAC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, BBNX is more volatile compared to EXAC. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check EXAC's competition here
BBNX vs ABAX Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, ABAX has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while ABAX trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas ABAX's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to ABAX's ROE of +0.10%. Regarding short-term risk, BBNX is more volatile compared to ABAX. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check ABAX's competition here
BBNX vs COTV Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, COTV has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while COTV trades at $44.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas COTV's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to COTV's ROE of +0.14%. Regarding short-term risk, BBNX is more volatile compared to COTV. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check COTV's competition here
BBNX vs LDR Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, LDR has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while LDR trades at $67.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas LDR's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to LDR's ROE of +1.17%. Regarding short-term risk, BBNX is more volatile compared to LDR. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check LDR's competition here
BBNX vs LPNT Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, LPNT has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while LPNT trades at $64.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas LPNT's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to LPNT's ROE of +0.05%. Regarding short-term risk, BBNX is more volatile compared to LPNT. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check LPNT's competition here
BBNX vs MEDC Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, MEDC has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while MEDC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas MEDC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to MEDC's ROE of N/A. Regarding short-term risk, BBNX is less volatile compared to MEDC. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check MEDC's competition here
BBNX vs EVHC Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, EVHC has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while EVHC trades at $45.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas EVHC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to EVHC's ROE of +0.07%. Regarding short-term risk, BBNX is more volatile compared to EVHC. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check EVHC's competition here
BBNX vs ABCO Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, ABCO has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while ABCO trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas ABCO's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to ABCO's ROE of +0.19%. Regarding short-term risk, BBNX is more volatile compared to ABCO. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check ABCO's competition here
BBNX vs CYNO Comparison May 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 421.6M. In comparison, CYNO has a market cap of 0. Regarding current trading prices, BBNX is priced at $9.37, while CYNO trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -6.91, whereas CYNO's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.23%, compared to CYNO's ROE of +0.03%. Regarding short-term risk, BBNX is more volatile compared to CYNO. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check CYNO's competition here